Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

392.79 +2.49 (+0.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Is This Beaten-Down Stock a Buy on the Dip?
It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive entry point. 
Via The Motley Fool
2 Growth Stocks That Are No-Brainer Buys Right Now
These stocks have outperformed broader equities over the past decade and still have room to run. 
Via The Motley Fool
VRTX Q2 2025 Deep Dive: New Product Launches and Pipeline Update in a Volatile Market
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $2.96 billion. The company expects the... 
Via StockStory
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
 
Via Benzinga
Vertex Pharmaceuticals Unusual Options Activity
 
Via Benzinga
Vertex Stock Sinks 12% As Pipeline Setbacks Trigger Wall Street Skepticism: But Retail Sees Opportunity
Via Stocktwits
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
1 Cash-Producing Stock for Long-Term Investors and 2 We Brush Off
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Gartner, Eli Lilly, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (August 4-August 8): Are The Others In Your Portfolio?
Large-cap laggards slid on weak results/guidance, cuts and capital moves—led by The Trade Desk, Fortinet, Super Micro, Gartner and Eli Lilly. 
Via Benzinga
The Smartest Growth Stocks to Buy With $1,000 Right Now
There's no guarantee that any stock will beat the market, but the chances look good for these three. 
Via The Motley Fool
Topics Artificial Intelligence
5 Top Stocks to Buy in August
Even with the S&P 500 near an all-time high, there are plenty of compelling growth, dividend, and value stocks to buy now. 
Via The Motley Fool
Topics Economy Stocks
Unusual volume S&P500 stocks in Thursday's session
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
The Best Stocks to Invest $1,000 In Right Now
Market volatility could increase in the months ahead, but these stocks should hold up well. 
Via The Motley Fool
Topics Economy Government World Trade
Which S&P500 stocks have an unusual volume on Wednesday?
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below. 
Via Chartmill
Which S&P500 stocks are moving on Wednesday?
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Strong Affordable Growth Pick with Solid Fundamentals
Vertex Pharmaceuticals (VRTX) offers strong growth, solid profitability, and reasonable valuations, making it a top pick for affordable growth investors. 
Via Chartmill
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
There's more good news than bad news for this big biotech stock. 
Via The Motley Fool
Topics Earnings
Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red. 
Via Chartmill
Topics Economy
Why Vertex Pharmaceuticals (VRTX) Stock Is Trading Lower Today
Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) fell 17.4% in the afternoon session after the company announced its experimental pain drug, VX-993, failed a key mid-stage clinical trial.... 
Via StockStory
Topics Artificial Intelligence
Top S&P500 movers in Tuesday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
Weakness In Vertex Stock Seen As Buying Opportunity
Vertex stock falls after pain drug VX-993 fails Phase 2 trial, despite better-than-expected Q2 earnings and strong cystic fibrosis drug sales. 
Via Benzinga
These Analysts Cut Their Forecasts On Vertex Pharmaceuticals After Q2 Results
 
Via Benzinga
Stock Market Rollercoaster: Wall Street Navigates Sharp Swings and Rebounds in Early August
The financial markets have been on a tumultuous ride in early August 2025, experiencing a dramatic "see-saw" pattern that has left investors both wary and hopeful. Following a sharp decline at the... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Which S&P500 stocks have an unusual volume on Tuesday?
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Which S&P500 stocks are moving on Tuesday?
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Assessing Vertex Pharmaceuticals: Insights From 9 Financial Analysts
 
Via Benzinga
Discover the top S&P500 movers in Tuesday's pre-market session.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.